170 - Understanding and Preventing Viral Gastroenteritis

Friday, October 13, 2023

1:45 PM – 3:00 PM US ET

Location: 153 ABC

All relevant financial disclosures have been mitigated.

Moderator(s)

Christine Johnston, MD, MPH (she/her/hers)

Associate Professor
Medicine
University of Washington
Seattle, WA, United States
Angela Campbell, MD, MPH, FPIDS, FIDSA

Medical Officer
Centers for Disease Control and Prevention
Atlanta, GA, United States

Faculty(s)

Andi Shane, MD, MPH, MSc

Professor
Department of Pediatrics, Division of Infectious Diseases
Emory University School of Medicine and Children's Healthcare of Atlanta
Atlanta, GA, United States

Slides
Robert Atmar, MD

Professor
Baylor College of Medicine
Houston, TX, United States

Slides
Rachel Burke, PhD MPH (she/her/hers)

Program Officer, Polio
Bill & Melinda Gates Foundation
Seattle, WA, United States

Slides

Disclosure(s):

Christine Johnston, MD, MPH: Assembly Biosciences: Advisor/Consultant (Ongoing); Gilead: Grant/Research Support (Ongoing); GSK: Advisor/Consultant (Ongoing); UpToDate Wolters Kluwer Health: Royalties (Ongoing)

Angela P. Campbell, MD, MPH, FPIDS, FIDSA: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the impact of viral gastroenteritis in the United States;
explain emerging strategies for the treatment and prevention of norovirus;
recognize successes and challenges of the global rotavirus vaccine effort

Presentations:

1:45 PM – 2:10 PM US ET

What You and Your Patients Need to Know About the Epidemiology of Viral Gastroenteritis
Speaker: Andi L. Shane, MD, MPH, MSc – Emory University School of Medicine and Children's Healthcare of Atlanta
2:10 PM – 2:35 PM US ET

Norovirus: Bench to Bedside
Speaker: Robert L. Atmar, MD – Baylor College of Medicine
2:35 PM – 3:00 PM US ET

Global Impact of Rotavirus Vaccines
Speaker: Rachel M. Burke, PhD MPH (she/her/hers) – Bill & Melinda Gates Foundation